Paul Tudor Jones Invitae Corp Transaction History

Tudor Investment Corp Et Al

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $76,436 - $173,892	-63,697 Reduced 10.5%	542,704 $733,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $351,693 - $742,465	205,669 Added 51.32%	606,401 $1.13 Million
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $516,659 - $2.35 Million	-271,926 Reduced 40.43%	400,732 $986,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $235,997 - $998,280	110,797 Added 19.72%	672,658 $1.64 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $2.16 Million - $5.36 Million	343,554 Added 157.37%	561,861 $4.48 Million

Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $3.21 Million - $6.26 Million	218,307 New	218,307 $3.33 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.58 Million - $2.45 Million	-60,526 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $414,936 - $714,528	12,551 Added 26.16%	60,526 $2.31 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $1.88 Million - $2.75 Million	47,975 New	47,975 $2.01 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $173,022 - $261,675	-9,961 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $106,084 - $256,495	9,961 New	9,961 $233,000
Q2 2018 Aug 14, 2018	SELL	$4.87 - $8.42 $243,500 - $421,000	-50,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $234,500 - $502,500	50,000 New	50,000 $235,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.